FDA granted accelerated approval for Mekinist (trametinib) in combination with Tafinlar (dabrafenib) for unresectable melanoma or metastatic melanoma with BRAF V600E or V600K mutations.
Elizabeth Comen originally set out to write a book about the wellness industry, but ended up writing a different book altogether.
